Elan Corporation (ELN) Problems with one of the company’s major drugs. Falls to $9.55 from 52-week high of $37.45.

Gatehouse (GHS) More poor newspaper earnings raise issue of whether company is viable. Falls to $.48 from 52-week high of $17.43.

Gold Fields (GFI) Tough earnings and COO out. Off to $9.98 from 52-week high of $19.92

CBS (CBS) Market does not like earnings. Dips to $15.83 from 52-week high of $32.97.

Tomotherapy (TOMO) Reports reduced orders. Falls to $4.94 from 52-week high of $26.80.

Biogen Idec (BIIB) Major trouble with important drug product. Down to $50 from 52-week high of $84.75.

Douglas A. McIntyre